Gut-targeted antidepressants: A novel approach to battling depression and anxiety News-Medical.Net
Scientists Find Promising New Target for Antidepressants—In the Gut NYU News
SPN-820: Rapid-Acting Antidepressant Shows Promising Phase 2 Results Psychiatric Times
Antidepressants May Act in Gut to Reduce Depression and Anxiety Columbia University Irving Medical Center
How many suicides does it take until regulators take drastic action? NationalWorld
Interprofessional George Mason researchers awarded more than $1 million to improve outcomes for patients with depression Department of Health Administration and Policy
Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential Carcinogen Health.com
What is Duloxetine? Antidepressant Drug Recalled by FDA MSN
What is Duloxetine? Antidepressant Drug Recalled by FDA Newsweek
